MedTrace Logo

THE EFFECT OF CANCER AWARENESS WEB-BASED EDUCATION IN SCHOOLS

NCT07614711 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2026-05-29

No results posted yet for this study

Summary

Objective: This study aims to determine the effect of web-based cancer awareness education in schools on students' knowledge levels, help-seeking attitudes, and stigma attitudes.

Method: The Web-Based Adolescent Cancer Education (WAKE) study was planned as a school-based, randomized controlled experimental study. Qualified high schools in the public sector of Izmir province will constitute the study population. Private schools are excluded for adolescents whose additional needs cannot be met in inclusive education. Two schools will be selected using a purposive sampling method (15-18 age group) and assigned to the experimental and control groups. This will prevent interaction between students in both schools. Students in each school will be listed, and assignments to groups will be made using a web-based randomizer application with randomly selected numbers (https://www.randomizer.org/). Data will be collected using the Cancer Awareness Scale (CAM), the Cancer Stigma Scale (CASS-T), and a Basic Demographic Questionnaire. In the evaluation of the data, descriptive statistics (number, percentage, and statistic) will be used, and repeated measures analysis of variance will be employed to assess the effect of the intervention. Differences in results between the experimental and control groups will be tested using multiple regression methods.

Conditions

  • Cancer Awareness and Prevention Education

Interventions

BEHAVIORAL

Web-Based Cancer Awareness Education

A web-based educational program designed to improve students' cancer-related knowledge, help-seeking behaviors, and attitudes toward cancer-related stigma.

Sponsors & Collaborators

  • Dokuz Eylul University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
15 Years
Max Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2026-03-01
Primary Completion
2026-06-30
Completion
2026-06-30

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07614711 on ClinicalTrials.gov